United States · How much has Bantam Pharmaceutical raised?
Bantam Pharmaceutical has raised $25M across 1 round since 2021.
United States · Seed startup
Who invested in Bantam Pharmaceutical
One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Bantam Pharmaceutical and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$25Mraised across 1 round since 2021, from 1 source
- Latest round
- Seed, $25MSept 2021
- Investors
- 0
The rounds
- Sept 2021Seed$25M
No investor was named in the report.
Source recorded
Funding filed with regulators
Bantam Pharmaceutical filed one raise, $7.0M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jul 2015$7.0MSEC Form D
Founders and team
From Bantam Pharmaceutical's own website and the SEC filings it signed: 7 on the team.
- Michael StocumPresident, CEO
- Matthew KosturaChief Scientific Officer
- Meghan ReynoldsChief of Staff
- Dr. Andy AnanthaHead of CMC
- Lori McDermottHead of Clinical Operations
- Lionel F. GoldfrankManageri
- W. James F. TozerManageri
Quick answers about Bantam Pharmaceutical
When did Bantam Pharmaceutical last raise?
Bantam Pharmaceutical's most recent round was a Seed of $25M in Sept 2021.
What was Bantam Pharmaceutical's biggest round?
Its most recent round, $25M in Sept 2021, is also its largest on record.
What stage is Bantam Pharmaceutical at?
Bantam Pharmaceutical's latest named round is a Seed, in Sept 2021.
Where is Bantam Pharmaceutical based?
Bantam Pharmaceutical is based in the United States.
Companies like Bantam Pharmaceutical
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.